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Abstract  36 
Increased legal availability of cannabis has led to a common misconception that it is a safe 37 
natural remedy for, amongst others, pregnancy-related ailments like morning sickness. 38 
Emerging clinical evidence, however, indicates that prenatal cannabis exposure (PCE) 39 
predisposes offspring to various neuropsychiatric disorders linked to aberrant 40 
dopaminergic function. Yet, our knowledge of how cannabis exposure affects the 41 
maturation of this neuromodulatory system remains limited. Here, we show that male, but 42 
not female, offspring of ∆9-tetrahydrocannabinol (THC)-exposed dams, a rat PCE model, 43 
exhibit extensive molecular and synaptic changes in dopaminergic neurons of the ventral 44 
tegmental area, including altered excitatory-to-inhibitory balance and switched polarity of 45 
long-term synaptic plasticity. The resulting hyperdopaminergic state leads to increased 46 
behavioral sensitivity to acute THC during pre-adolescence. The FDA-approved 47 
neurosteroid pregnenolone rescues synaptic defects and normalizes dopaminergic activity 48 
and behavior in PCE offspring, suggesting a therapeutic approach for offspring exposed to 49 
cannabis during pregnancy. 50 
51 
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Main text  52 
The use of cannabis among pregnant women is increasing, with a prevalence rate of 3-53 
16% in Western societies1-4. In association with the booming of cannabis marketing and 54 
the increased perception of its safety, cross-sectional analyses indicate that cannabis is 55 
often recommended to pregnant women as a treatment for morning sickness5. Although 56 
the use of medical cannabis for nausea and vomiting is approved in several states and 57 
countries, no legal distinction or warning for its use during pregnancy is mentioned6. 58 
Additionally, doctors or other health-care practitioners seldom advise pregnant women 59 
about the risks of taking cannabis during pregnancy6, 7.  60 
The main psychoactive ingredient of cannabis, ∆-tetrahydrocannabinol (THC), interferes 61 
with the endocannabinoid system, which tightly controls progenitor cell proliferation and 62 
neuronal differentiation, axon growth and pathfinding, synapse formation and pruning in 63 
the developing brain3, 8-10. Accordingly, four independent longitudinal clinical studies 64 
demonstrated that prenatal cannabis exposure (PCE) predisposes to a wide array of 65 
behavioral and cognitive deficits including hyperactivity, enhanced impulsivity, loss of 66 
sustained attention, increased sensitivity to drugs of abuse11-13 and susceptibility to 67 
psychosis14. Notably, all these neuropsychiatric impairments are tied to dysfunction of 68 
dopaminergic signaling15, 16. While the effects of acute and chronic cannabis use during 69 
adolescence and adulthood have been investigated17-19, the impact of PCE on dopamine 70 
neurons within the ventral tegmental area (VTA), key players in motivation, reward and 71 
cognition20, remains to be elucidated. 72 
The “two-hit” model of psychiatric disorders posits that genetic background and/or 73 
environmental insults act as a “first hit”, perturbing brain development in a manner that 74 
leads to susceptibility to the onset of psychiatric symptoms upon a “second hit”. First hits 75 
can also lead to endophenotypes such as neurobehavioral deficits21, 22, and characterizing 76 
4 
 
these may help to elucidate altered trajectories of circuit development that increase 77 
susceptibility to subsequent challenges22, 23, which may in turn enable prevention of 78 
disease emergence. Notably, PCE was recently suggested to act as a “first hit” by 79 
interfering with the known complex developmental functions of endocannabinoid signaling, 80 
3, 9, 23.  81 
Longitudinal studies evaluating the behavioral effects of PCE on offspring have 82 
consistently shown increased impulsivity, increased incidence of risk-taking behaviors, and 83 
vulnerability to psychosis and enhanced sensitivity to drugs of abuse later in life, which can 84 
be detected as early as early infancy and throughout child development11, 12, 14. 85 
Furthermore, it is predicted that the ratio of affected children developing prenatal THC-86 
induced endophenotypes is likely to be substantially higher24, 25, but the complexity of 87 
uncontrollable genetic, environmental, and socioeconomic factors in humans makes the 88 
determination of causality very difficult. This highlights the advantage of animal models 89 
that mimic specific genetic and environmental factors.  Here, we tested the hypothesis that 90 
PCE triggers molecular and synaptic changes in the VTA, leading to aberrant 91 
dopaminergic activity and behavioral susceptibility to subsequent challenges. In 92 
agreement with evidence that the first clinical neuropsychiatric symptoms manifest as early 93 
as infancy in PCE offspring11, 14, 24, we find that prenatal THC exposure modeling PCE 94 
(hereafter referred to just as “PCE”) engenders “silent” functional abnormalities such as 95 
impaired sensorimotor gating, increased risk-taking and abnormal locomotor responses to 96 
THC in juvenile male offspring that become overt when acutely challenged with THC. 97 
Enhanced excitability of VTA dopamine neurons and larger THC-induced dopamine 98 
release accompany the PCE-induced endophenotype. Furthermore, we observe altered 99 
excitatory/inhibitory balance of VTA dopamine cells along with switched polarity from long-100 
term depression to long-term potentiation at afferent excitatory synapses. Postnatal 101 
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administration of pregnenolone, a Federal Drug Agency (FDA)-approved drug, which is 102 
currently under investigation in clinical trials for cannabis use disorder, schizophrenia, 103 
autism and bipolar disorder (ClinicalTrials.gov Identifiers NCT00728728, NCT00615511, 104 
NCT02811939, NCT01881737, NCT02627508, NCT00223197, NCT01409096), 105 
normalized dopamine neuron excitability, restored synaptic properties and abnormal 106 
polarity of synaptic plasticity, as well as THC-induced dopamine release and deficits of 107 
sensorimotor gating functions.  108 
 109 
Results 110 
PCE induces a distinct behavioral endophenotype 111 
To test the hypothesis that PCE triggers behavioral dysfunctions by altering midbrain 112 
dopaminergic activity, we modeled PCE by administering rat dams with THC (2 mg/kg s.c. 113 
once daily) during pregnancy (from gestational day 5 until 20). This low THC dose does 114 
not recapitulate behavioral responses in the cannabinoid tetrad assay or elicits 115 
cannabinoid tolerance after repeated administration26, hence it represents a mild insult 116 
without any substantial direct impact on maternal behavior. We did not detect changes in 117 
litter size, maternal and non-maternal behavior, and in offspring body weight at this dose 118 
(Supplementary Fig. 1), indicating that malnutrition and maternal care did not account for 119 
any observed behavioral effects in the offspring. In terms of human consumption, this dose 120 
is equivalent to THC content in mild joints (5%)27, since average THC content in illicit 121 
cannabis preparations has significantly increased in the last two decades (from ~4% to 122 
~12%)28.  123 
To assess early signs of altered neurodevelopmental trajectories related to PCE 124 
endophenotypes, we tested offspring in a series of behavioral tasks, under basal 125 
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conditions and then following an acute THC (2.5 mg/kg s.c.) or vehicle (VEH) challenge 126 
during the third and fourth postnatal week (postnatal day 15-28), corresponding to human 127 
pre-adolescence. This is because in the “clinical staging model”, subclinical symptoms are 128 
shown before adolescence and early adulthood29, and a prominent research goal is the 129 
identification of such endophenotypes22. Moreover, in healthy human subjects, cannabis 130 
induces a wide range of deficits resembling the phenomenology of schizophrenia spectrum 131 
disorders19, 30. Thus, we first investigated whether PCE alters sensorimotor gating 132 
functions by using pre-pulse inhibition (PPI) of the acoustic startle reflex. Measures of 133 
sensorimotor gating are among the most widely studied physiological markers used in 134 
animal models of schizophrenia, and PPI deficits are present in patients with psychotic 135 
disorders31. Notably, we found that PCE did not affect PPI per se. On the other hand, an 136 
acute THC challenge disrupted PPI parameters in the PCE group but remained ineffective 137 
in control (CTRL) offspring (Fig. 1a). Because this effect was sex-dependent and specific 138 
for this developmental milestone (Fig. 1b; Supplementary Fig. 2a), all experiments 139 
hereafter were carried out in male pre-adolescent rats. To test if PCE induces an 140 
endophenotype associated with altered mesolimbic dopamine transmission, we next 141 
performed in vivo cerebral microdialysis experiments in the shell of Nucleus Accumbens 142 
(NAcS), one of the major target areas of midbrain VTA dopamine neurons 143 
(Supplementary Fig. 2b-d). In accordance with our behavioral observations, we did not 144 
detect alterations in basal extracellular dopamine levels, but the response to acute THC 145 
administration was significantly larger in the PCE offspring group (Fig. 1c), indicating that 146 
the mesolimbic dopamine system becomes sensitized following maternal THC use. 147 
Moreover, we found that THC-induced disruption of PPI significantly and positively 148 
correlated with the levels of dopamine in the NAcS (Fig. 1d) and required enhanced 149 
mesolimbic dopamine signaling, because the inhibitor of tyrosine hydroxylase prevented 150 
PPI deficits (Fig. 1e). 151 
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We next examined the effects of PCE on spontaneous locomotor responses to acute THC 152 
in an open field. No differences were observed between progenies, unless they were 153 
acutely treated with THC, as revealed by increased locomotor parameters (Fig. 1f, 154 
Supplementary Fig. 3a,b). These effects on spontaneous locomotion were causally 155 
dependent on VTA dopamine neuron function, because chemogenetic silencing of 156 
dopaminergic neurons by Gi-coupled DREADD (hM4Di) stimulation, counteracted the 157 
paradoxical hyperlocomotion elicited by THC in PCE offspring (Fig. 1g, Supplementary 158 
Fig. 3c,d). Next, we assessed whether the hyperlocomotion and reduced thigmotaxis 159 
observed in PCE after a single exposure to THC were associated to behavioral 160 
disinhibition. We tested the progenies in the dopamine-dependent suspended wire-beam 161 
bridge task, which measures the proclivity to engage in impulsive risk-taking behaviors. 162 
This task is operationally defined as the latency to access and move across an unstable 163 
bridge and to display stretched-attend postures, an ethologically relevant rodent behavior 164 
that occurs during risk assessment. PCE offspring were more prone to cross the bridge 165 
(Fig. 1h) and displayed a markedly impaired evaluation of risk assessment (Fig. 1i). 166 
Importantly, the propensity of PCE animals to take risks was not associated with 167 
alterations in emotional components, because progenies did not differ in the amount of 168 
defensive responses to sudden acoustic stimuli measured by startle amplitude 169 
(Supplementary Fig. 3e). Furthermore, they did not display differences in anxiety-related 170 
behavior assessed by the number of entries/time spent in open or closed arms, and in the 171 
number of transitions in the center on the elevated plus maze (Supplementary Fig. 3f,g).  172 
PCE increases dopamine neuron excitability  173 
We next determined the neurobiological mechanisms underlying heightened dopamine 174 
release associated with the behavioral susceptibility observed in PCE offspring. Because 175 
type-1 and type-2 cannabinoid (CB1 and CB2) receptors, molecular targets of THC, 176 
8 
 
regulate progenitor cell proliferation in the developing brain8, we first investigated by 177 
confocal microscopy whether PCE alters the number of TH-positive cells or the intensity of 178 
TH-immunostaining in the VTA. Neither TH-positive dopamine neuron density 179 
(Supplementary Fig. 4a-e), nor TH levels measured in individual cells (Supplementary 180 
Fig. 4f) were different. We next probed the function of dopamine neurons by using whole-181 
cell patch-clamp recordings to assess whether PCE-induced changes in physiological 182 
properties of dopaminergic neurons promote enhanced release. We performed current-183 
clamp recordings in the lateral portion of the VTA, where cell bodies of the majority of 184 
dopamine neurons projecting to the NAcS reside32, and we verified the TH-185 
immunopositivity of the recorded neurons by post-hoc confocal microscopy. Dopamine 186 
neurons obtained from PCE offspring showed a different electrophysiological profile: they 187 
spontaneously fired at a higher frequency and displayed depolarized resting membrane 188 
potentials (Fig. 2a-c). Moreover, PCE dopamine neurons exhibited an overall increased 189 
excitability and higher maximum spiking frequencies in response to somatically injected 190 
currents (Fig. 2d). We also observed a reduced latency to action potential onset, the time 191 
needed for the first spike appearance in response to the smallest current injection (Fig. 192 
2e). Moreover, a larger proportion of dopamine neurons fired action potentials (16/20, 193 
80%) when compared to CTRL offspring (5/21 cells, ~23%; Fig. 2e) and showed 194 
enhanced spike fidelity (Supplementary Fig. 5a-d). This is consistent with decreased 195 
spike threshold in response to depolarizing current pulses in neurons from PCE slices 196 
(Fig. 2f). In contrast, we did not detect alterations in the after-hyperpolarization period 197 
following successive action potentials (Fig. 2g-h), in membrane capacitance or in inter-198 
spike intervals (Supplementary Fig. 5e,f). Finally, PCE also modifies dopamine cell 199 
responses to acute THC by increasing spontaneous and evoked activity and enhancing 200 
spike fidelity in a dose- and CB1 receptor- dependent manner (Supplementary Fig. 6). 201 
Collectively, these results suggest that PCE biases the dopamine system by changing the 202 
9 
 
intrinsic properties of dopamine neurons and endowing them with a hyper-excitable 203 
phenotype, an underlying clinical feature of diverse psychiatric disorders16, 20.  204 
PCE shifts excitatory and inhibitory synaptic weights to dopamine neurons 205 
To further address how PCE affects VTA dopamine neurons, we examined their synaptic 206 
properties. First, we observed a robust increase in the excitation-to-inhibition (E/I) ratio of 207 
dopamine neurons from PCE slices (Fig. 3a). To elucidate the underlying mechanisms of 208 
this phenomenon, we calculated AMPA/GABAA and NMDA/GABAA ratios (Supplementary 209 
Fig. 7a-c) and produced input-output curves from the responses measured at different 210 
stimulus intensities. A substantial decrease in synaptic inhibition of VTA dopamine cells 211 
obtained from PCE rats was revealed (Fig. 3b, Supplementary Fig. 7a-c). To assess 212 
whether this change arises from presynaptic mechanisms, we first computed the 213 
1/coefficient of variation2 (1/CV2) value, which is an independent measure of changes in 214 
presynaptic function33. We found that PCE markedly decreases 1/CV2 of IPSCs at lower 215 
stimulus intensities indicating reduced release probability at inhibitory synapses (Fig. 3c). 216 
Additionally, PCE increased the paired-pulse ratio (PPR) of GABAA IPSCs 217 
(Supplementary Fig. 7d,e), and decreased the frequency, but not the amplitude of 218 
miniature IPSCs (mIPSCs) (Supplementary Fig. 7f-h).  219 
Recent correlated electrophysiological and super-resolution imaging measurements have 220 
uncovered that the clustering of the cytomatrix protein bassoon in the presynaptic active 221 
zone is a reliable predictor of presynaptic release probability34. This is because augmented 222 
bassoon density inhibits the recruitment of voltage-gated calcium channels required for 223 
action potential-dependent vesicle release34. To identify the molecular substrates 224 
contributing to reduced synaptic inhibition of VTA dopamine cells from PCE animals, we 225 
combined confocal and stochastic optical reconstruction microscopy (STORM) and 226 
quantified bassoon density measured with nanometer precision within identified inhibitory 227 
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axon terminals impinging on the dendrites of dopamine neurons (Fig. 3d). We observed a 228 
substantial increase (by 45%) in the nanoscale density of bassoon at GABAergic synapses 229 
obtained from the PCE group (Fig. 3e,f, Supplementary Fig. 8c). In contrast, there was 230 
no change in the number and size of inhibitory boutons and their active zones, or in 231 
vesicular GABA transporter levels (Supplementary Fig. 8). Collectively, these data 232 
demonstrate that PCE induces a specific change in the presynaptic nanoarchitecture of 233 
inhibitory synapses and suggest that increased molecular crowding at vesicle release 234 
sites34 contributes to the reduced synaptic inhibition of dopamine neurons.  235 
CB1 receptors are among the most abundant metabotropic regulators of neurotransmitter 236 
release probability35. Compelling anatomical and electrophysiological evidence shows that 237 
CB1 activation decreases GABA release thereby sculpting the activity of dopamine 238 
signaling36, 37. Therefore, we tested the hypothesis that enhanced cannabinoid receptor 239 
control at inhibitory synapses contributes to reduced synaptic inhibition. The mixed 240 
CB1/CB2 receptor agonist WIN 55,212-2 (WIN) produced a larger and faster effect on 241 
evoked IPSC amplitude recorded from VTA dopamine cells in PCE offspring (Fig. 3g-i). 242 
However, STORM imaging showed no difference in CB1 levels at GABAergic afferents to 243 
dopamine neurons (Fig. 3j). These nanoscale super-resolution data together indicate that 244 
the ratio of the presynaptic regulatory CB1 receptors and their molecular effectors in the 245 
release machinery complex shifted so that less voltage-gated calcium channels are 246 
controlled by a similar number of CB1 receptors on inhibitory axon terminals in the PCE 247 
group versus the CTRL group. This implies that a saturating dose of the CB1 agonist WIN 248 
should have the same effects on GABAA IPSC amplitude, and that WIN effects on IPSCs 249 
should be faster, which was in fact the case (Fig. 3i). Altogether, these findings 250 
demonstrate that PCE induces a molecular reorganization of the active zone leading to 251 
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increased presynaptic cannabinoid control along with markedly reduced GABAergic 252 
inhibition. 253 
To gain insights into the consequences of PCE on excitatory synaptic transmission, we 254 
first measured input-output curves from responses elicited at different stimulus intensities. 255 
We found that a larger stimulus intensity is required to recruit the same magnitude of 256 
synaptic excitation indicating that PCE induces reduction in the number and/or strength of 257 
excitatory inputs terminating on dopamine neurons (Fig. 4a). Indeed, confocal microscopy 258 
analysis uncovered a robust (~50%) reduction in the density of type I vesicular glutamate 259 
transporter (vGluT1)-positive excitatory axon terminals contacting TH-positive 260 
dopaminergic neurons in the lateral VTA (Supplementary Fig. 9a-c). On the other hand, 261 
there were no differences in the 1/CV2 values of EPSCs (Fig. 4b), in their PPR 262 
(Supplementary Fig. 9d,e) or in the frequency of mEPSCs (Supplementary Fig. 9f,g). In 263 
contrast to the lack of presynaptic physiological changes, we observed an increased 264 
amplitude of mEPSCs (Supplementary Fig. 9f,h) and longer decay kinetics of 265 
postsynaptic AMPA currents (Fig. 4c), indicating that PCE affected the post-synaptic 266 
responsiveness of afferent excitatory synapses of VTA dopamine neurons. Likewise, PCE 267 
elicited a larger AMPA/NMDA ratio with the frequency distribution curve shifted to the right 268 
in dopamine cells of PCE offspring (Fig. 4d-f). Notably, similar increases in the 269 
AMPA/NMDA ratio are observed in VTA dopamine neurons of offspring exposed in utero 270 
to cocaine or alcohol38, 39. Thus, potentiated AMPA/NMDA ratios in the postnatal PCE 271 
brain directly reflects prenatal drug exposure. We also computed NMDA EPSC decay time 272 
kinetics, measured as weighted tau (τ), and found that they were faster in neurons 273 
recorded from the PCE progeny (Fig. 5a,b), and were more sensitive to GluN2A blockade 274 
(Fig. 5c), indicative of an increased ratio GluN2A/N2B subunits in NMDA receptors38. 275 
Next, we examined the current-voltage relationship (I–V) of AMPA EPSCs. When 276 
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compared to CTRL animals, PCE offspring I-V curves were non-linear, exhibited inward 277 
rectification (Fig. 5d,e) and the GluA2 blocker NASPM reduced AMPA EPSCs to a larger 278 
extent (Fig. 5f), indicating the insertion of calcium permeable (i.e., GluA2-lacking) AMPA 279 
receptors38, 39. Taken together, these microscopic and electrophysiogical results suggest 280 
that PCE delays the molecular and anatomical maturation of excitatory synaptic inputs on 281 
VTA dopaminergic neurons, leading to increased postsynaptic responsiveness, a well-282 
known property of developing brain circuits. 283 
A major consequence of reduced inhibitory control of dopamine neurons together with 284 
heightened responsiveness to their excitatory inputs might also be a shift in the threshold 285 
for synaptic plasticity induction. Pairing low-frequency presynaptic stimulation (LFS, 1 Hz) 286 
with post-synaptic membrane depolarization (-40 mV) resulted in the expected long-term 287 
depression (LTD) of excitatory synapses40. In contrast, we found that the very same 288 
stimulus protocol elicited a marked long-term potentiation (LTP) in VTA dopamine neurons 289 
from PCE animals (Fig. 5g,h), an effect reminiscent of immature glutamatergic synapses.  290 
We next examined whether the synaptic effects of PCE were cell-type-specific in the 291 
lateral VTA circuitry. GABA and dopamine neurons, which make up the vast majority of 292 
neurons in the lateral VTA41 (Supplementary Fig. 10a,b), could be reliably distinguished 293 
by their morphological and electrophysiological characteristics and by the absence or 294 
presence of TH42 in post-hoc immunofluorescence analysis, respectively (Supplementary 295 
Fig. 10c-l). While PCE did not affect E/I balance, it decreased the AMPA/NMDA ratio 296 
(Supplementary Fig.11a,b). Notably, NMDA EPSC decay time, I-V of AMPA EPSCs, 297 
PPR of both AMPA EPSCs and GABAA IPSCs in putative GABA cells did not differ 298 
between progenies (Supplementary Fig.11c-f). Thus, PCE does not alter the content of 299 
GluA2-containing AMPARs and GluN2A-containing NMDARs at these synapses onto VTA 300 
putative GABA neurons but specifically modifies EPSC generation. Collectively, these 301 
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findings suggest that PCE predominantly affects the synaptic maturation of dopamine cells 302 
within the VTA circuitry. 303 
Pregnenolone rescues dopamine function and behavior after PCE 304 
Since preventative strategies to reduce the burden of PCE in offspring are currently not in 305 
place7, the identification of the PCE endophenotype is instrumental to test therapeutic 306 
interventions during prodromal phases of late-onset psychiatric disorders. Particularly, 307 
early interventions are needed prior to the time point at which PCE offspring manifest the 308 
age of risk for a disorder to prevent phenoconversion to late-onset disease14, 29, 43 .   309 
The FDA-approved neurosteroid pregnenolone (PREG) reverses behaviors such as 310 
psychomotor agitation and deficits in PPI that are observed in individuals with 311 
schizophrenia 44. Notably, it also acts as a negative regulator of CB1 receptor signaling45. 312 
Therefore, we predicted that a short postnatal treatment of PCE offspring with PREG 313 
would be a good candidate for reversing PCE-induced changes in the properties of VTA 314 
dopamine neurons and behavior. To assess this, we administered PREG (6 mg/kg s.c. 315 
once daily for 9 days, from PND 15 to 23) to VEH or PCE offspring, and acute VTA-316 
containing slices were prepared 1 and 2 days following the last administration (Fig. 6a), 317 
when PREG is cleared from the brain. Remarkably, PREG rescued LTD at excitatory 318 
synapses on dopamine neurons to CTRL levels (Fig. 6b), without affecting synaptic 319 
efficacy in CTRL offspring. Moreover, PREG ameliorated PCE-induced dopamine neuron 320 
excitability in PCE slices, measured by resting membrane potential (Fig. 6c), as well as 321 
spontaneous (Fig. 6d-f) and evoked firing activity (Fig. 6g,h). PREG also fully restored the 322 
alterations in synaptic properties imposed by PCE on excitatory and inhibitory inputs on 323 
dopamine cells (Supplementary Fig. 12). Most importantly, PREG selectively prevented 324 
larger acute THC-induced enhancement of dopamine levels in NAcS (Fig. 6i,j), and THC-325 
induced disruption of somatosensory gating functions in PCE offspring (Fig. 6k). Finally, 326 
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we found that PREG mechanism of action was dissociated from its downstream 327 
neurosteroid metabolites (Supplementary Fig.13). Collectively, these results indicate that 328 
PREG prevents PCE-induced hyperdopaminergic states and confers resilience towards 329 
heightened acute effects of THC in PCE animals. 330 
 331 
Discussion 332 
In the present study, we provide evidence that maternal THC exposure induces 333 
multifaceted molecular, cellular and synaptic adaptations that converge into aberrant 334 
dopamine function in juvenile male rat offspring. Such persistently enhanced excitability of 335 
VTA dopamine neurons is a well-established neurodevelopmental risk factor conferring 336 
biased dopamine transmission and vulnerability to discrete psychiatric disorders. This 337 
might manifest in aberrant associative learning and abnormal reward processing, and 338 
provide an interpretative framework for clinical studies reporting maladaptive behaviors, 339 
ranging from affective dysregulation to psychosis and addiction vulnerability in the 340 
offspring of mothers using cannabis during pregnancy3, 11, 14. It is possible that the 341 
decreased expression of dopamine D2 receptors observed in human PCE offspring 342 
amygdala and nucleus accumbens46, 47 may be an adaptive response elicited by this 343 
hyperdopaminergic state, and may also contribute to the vulnerability to psychiatric 344 
disorders15.  345 
We propose that the hyperdopaminergic state and the activity-dependent synapse-specific 346 
remodeling identified in the present study are significant neurobiological substrates, which 347 
may promote a susceptible endophenotype conferred by maternal cannabis use. This is 348 
important because preclinical and clinical studies have also established a prominent and 349 
causative role for mesostriatal dopamine dysfunction, in particular elevated dopamine 350 
synthesis and release properties, in the pathophysiology of schizophrenia16. Notably, 351 
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positron emission tomography imaging studies have linked genetic risk for THC-induced 352 
psychosis to differential increases of dopamine release by THC48, a phenomenon 353 
exhibiting a high degree of familiarity49, raising the possibility that PCE offspring represent 354 
one proportion of cannabis users vulnerable for THC-induced psychosis50. Hence, PCE 355 
might be a risk factor conferring increased vulnerability to psychotic experiences as early 356 
as childhood14. Since PCE-induced dopamine dysregulation may predispose to THC-357 
dependent delusions and hallucinations, PCE may represent a relevant modifiable 358 
predictor of transition to psychotic disorder.  359 
Our findings are consistent with the protective actions of pregnenolone in acute THC 360 
intoxication in rodents45, and in an established mouse model for schizophrenia44 as a 361 
negative regulator of CB1 signaling. Although pregnenolone metabolites such as 362 
progesterone may have direct effects on GABA and NMDA receptors, the observation that 363 
inhibition of the converting enzyme 3β-hydroxysteroid dehydrogenase did not modify the 364 
protective effects of pregnenolone on PPI disruption induced by acute THC is consistent 365 
with the possibility that pregnenolone per se ameliorates PCE-induced physiological and 366 
behavioral dysfunctions. Since pregnenolone is a well-tolerated FDA-approved drug, 367 
devoid of major side effects45, our pharmacological treatment has high translational value 368 
as a safe and promising therapeutic approach for offspring of mothers who abused 369 
marijuana during pregnancy. Our study warrants further investigation into the effects of 370 
PCE on other anatomically and functionally heterogeneous dopamine subpopulations with 371 
different axonal projections. Indeed, since our recordings were carried out from the lateral 372 
portion of the VTA, which largely projects to the lateral shell of the NAc32, it is likely that 373 
these dopamine neurons would mainly project to this region.  374 
Finally, it is important to emphasize that some of the potentiated state measures of 375 
dopamine neurons resemble those described in VTA dopamine neurons of offspring 376 
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exposed in utero to cocaine or alcohol38, 39. As physicians caution pregnant women to not 377 
use alcohol and cocaine because of their detrimental effects to the fetus, based on our 378 
findings, it is our recommendation that they also advise them on the consequences of the 379 
use of cannabis during pregnancy. Considering that such preventative strategies do not 380 
take place due to the underestimation of the risks of neurodevelopmental adverse effects 381 
associated with maternal cannabis use6, 7, and that cannabis legalization policies move 382 
forward worldwide and conceivably large numbers of children will be prenatally exposed to 383 
its ingredients over the next decades, the present findings are critically important for 384 
unmasking and highlighting extensive neurobiological maladaptations that increase the 385 
vulnerability of at-risk offspring to neuropsychiatric disorders.  386 
 387 
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Materials and Methods 517 
Animals. All procedures were performed in accordance with the European legislation EU 518 
Directive 2010/63 and the National Institute of Health Guide for the Care and Use of 519 
Laboratory Animals and were approved by the Animal Ethics Committees of the University 520 
of Cagliari and by Italian Ministry of Health (auth. n. 659/2015-PR and 725/2019-PR) and 521 
by the Institutional Animal Use and Care Committee at the University of Maryland 522 
(0617002), Baltimore. We made all efforts to minimize pain and suffering and to reduce the 523 
number of animals used. Primiparous female Sprague Dawley (Envigo) rats (bred with 524 
males) were used as mothers and single housed during pregnancy. Long Evans dams 525 
expressing cre recombinase under the control of the tyrosine hydroxylase (TH) promoter 526 
(TH::Cre) were used for DREADDs experiments. ∆9-tetrahydrocannabinol (THC) or vehicle 527 
was administered (2 mg kg-1 2 ml kg-1s.c. once per day) from gestational day 5 (GD5) 528 
until GD20. Offspring were weaned at ~PND21 and maintained without any further 529 
manipulation in standard conditions of temperature (21 ± 1°C) and humidity (60%) on 530 
normal 12-h light/dark cycle with ad libitum access to food and water until the experimental 531 
day (PND 15-28). We did not use more than two males from each litter for the same 532 
experiment, to control for litter effect. All the additional male pups in each litter were used 533 
for other experiments (i.e. cerebral microdialysis, behavioral paradigms, STORM analysis, 534 
different electrophysiological protocols), in order to minimize the total number of animals.  535 
Surgical procedures 536 
TH::Cre positive offspring were stereotaxically injected under isoflurane (3% induction, 1-537 
2% maintenance) with a cre-dependent adeno-associated virus expressing an inhibitory 538 
DREADD construct (AAV5-DIO-hM4D(Gi)-mCherry, PCE-Gi), or control virus (AAV5-DIO-539 
mCherry, PCE) to target dopamine neurons in the ventral tegmental area (VTA) at 540 
postnatal day 7 (PND7). Viruses were injected at a volume of 0.5 μl/side and rate of 541 
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0.1 μl/min in the VTA (AP -4.2, LM ± 0.6 mm from bregma, and DV -5.25 mm from cortical 542 
surface) with a Hamilton syringe. Injection needles were left in place for 5 mins after the 543 
injection to assure adequate viral delivery. 544 
Behavioral analyses 545 
Maternal behavior observation. The behavior of each dam was assessed from PND 1 to 546 
PND 20 by an observer blind to the experimental groups until the analysis of data. The 547 
observation was performed five times per day at 9:00, 11:30, 13:30, 15:00 and 17:00 548 
during the light phase (lights on at 7:00) and consisted of 3 trials of instantaneous 549 
observation for a total of 15 observations per day and a total 300 observations per dam. 550 
As behavioral parameters: retrieval, arched-back, blanket and passive nursing, pup licking 551 
(regarded as maternal behaviors), self-grooming, eating, drinking, rearing, moving, resting, 552 
standing out of the nest (considered as non-maternal behaviors) were scored. Observation 553 
strictly followed the previously published detailed analysis51. Briefly, the behaviors were 554 
recorded using dichotomous scores (0/1): 0 was assigned when the behavior was not 555 
present, whereas it was scored as, 1 when it was present. Data were expressed as 556 
percentage of observation of maternal or non-maternal behavior. 557 
Startle reflex and Pre-pulse Inhibition. Startle reflex and Pre-pulse Inhibition (PPI) were 558 
tested as previously described52. Briefly, the apparatus (Med Associates) consisted of four 559 
standard cages placed in sound-attenuated chambers with fan ventilation. Each cage 560 
consisted of a Plexiglas cylinder of 5 cm diameter, mounted on a piezoelectric 561 
accelerometric platform connected to an analog-digital converter. Two separate speakers 562 
conveyed background noise and acoustic bursts, each one properly placed so as to 563 
produce a variation of sound within 1 dB across the startle cage. Both speakers and startle 564 
cages were connected to a main PC, which detected and analyzed all chamber variables 565 
with specific software. Before each testing session, acoustic stimuli and mechanical 566 
responses were calibrated via specific devices supplied by Med Associates. The testing 567 
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session featured a background noise of 70 dB and consisted of an acclimatization period 568 
of 5 min, followed by three consecutive sequences of trials (blocks). Unlike the first and the 569 
third block, during which rats were presented with only five pulse-alone trials of 115 dB, 570 
the second block consisted of a pseudorandom sequence of 50 trials, including 12 pulse-571 
alone trials, 30 trials of pulse preceded by 74, 78, or 86 dB pre-pulses (10 for each level of 572 
pre-pulse loudness), and eight no-stimulus trials, where only the background noise was 573 
delivered. Inter-trial intervals were selected randomly between 10 and 15 s. The % PPI 574 
value was calculated using the following formula: 100 − [(mean startle amplitude for pre-575 
pulse pulse trials/mean startle amplitude for pulse alone trials)*100]. PPI values related to 576 
different prepulse levels were collapsed, given that no interactions were found between 577 
pre-pulse levels throughout the study.  578 
Locomotor activity. Locomotor behaviors of Sprague Dawley and Long Evans TH::Cre rats 579 
were tested in two different facilities at the University of Cagliari (Italy) and at the 580 
University of Maryland School of Medicine (USA), respectively. Rats were placed in the 581 
center of a novel square open field (dimension: 42 x 42 x 30 cm, L x W x H) and their 582 
behavior was monitored for 40 min and collected every 10 minutes. Analysis of locomotor 583 
activity of Sprague Dawley and Long Evans TH::Cre rats were performed by using 584 
Omnitech Digiscan monitoring system (Omnitech Digiscan cages; Columbus, OH, USA) 585 
and Ethovision (Noldus Instruments, Wageningen, The Netherlands), respectively. 586 
Behavioral measurements included the assessment of the total distance traveled (cm), 587 
and the periphery and center time, respectively calculated as the durations of time spent 588 
along the perimeter of the walls (a 20-cm-wide external square frame) or in the center of 589 
the arena (an internal square measuring 20 x 20 cm). To minimize differences in baseline 590 
spontaneous locomotor activity (i.e., distance travelled), we normalized the data to their 591 
reference group (e.g., CTRL-VEH and PCE-VEH). For DREADD experiments, open field 592 
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testing was performed 30 minutes following systemic administration of clozapine-N-oxide 593 
(CNO, 3 mg/kg/2 ml i.p.) to engage VTA Gi-DREADDs. 594 
Elevated plus-maze. The test was performed as previously described53. Briefly, we used a 595 
black Plexiglas apparatus consisting of two opposing open arms (length: 40 cm, width: 9 596 
cm) and two closed arms (wall height: 15 cm), which extended from a central square 597 
platform (9 × 9 cm), positioned 70 cm from the ground. Rats were individually placed on 598 
the central platform facing the open arm. Behavior was recorded for 5 min. Measures 599 
included: entries and duration in the open and closed arms and the central platform; 600 
frequency of stretch-attend postures and head dips (defined as previously described).  601 
Wire-beam bridge test. Testing was performed on a variant of the protocol previously 602 
detailed54, 55, specifically adapted for rats. The apparatus consists of two 156 cm high 603 
Plexiglas platforms, connected by a horizontal, flexible wire-beam (100 cm long). A 52-cm 604 
high Plexiglas wall was placed on the proximity of the edge (3 cm from the edge) of one 605 
platform, in order to make the starting position uncomfortable and promote movement. The 606 
bridge consisted of 2 parallel beams (0.1 cm thick) perpendicularly connected by 34 607 
equally distanced cross-ties (3 cm long). It was modestly flexible, with a downward 608 
deflection of 2 cm per 100-g load at the center point. Rats were individually placed in the 609 
start position and the latency to cross and reach the other platform was recorded. The 610 
duration of overall immobility and number of crossings on ties were also monitored. 611 
Cerebral microdialysis. Rats were anesthetized with Equithesin and placed in a Kopf 612 
stereotaxic apparatus. In-house constructed vertical microdialysis probes (AN 69-HF 613 
membrane, Hospal-Dasco; cut-off 40,000 Dalton, 3 mm dialyzing membrane length) were 614 
implanted in the nucleus accumbens shell (AP: +1.5, L: ±0.7, V: -7.0 from bregma) 615 
according to atlas coordinates56, empirically corrected after pilot experiment. Rats were 616 
given antibiotic therapy (enrofloxacin, Bayer HealthCare, Shawnee Mission, KS) and 617 
allowed to recover in their home cages before testing. The day after probe implantation, 618 
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artificial cerebrospinal fluid solution (aCSF; 147 mM NaCl, 4 mM KCl, 1.5 mM CaCl2, 1 mM 619 
MgCl2, pH 6-6.5) was pumped through the dialysis probes at a constant rate of 1.1 µl min-620 
1 via a CMA/100 microinjection pump (Carnegie Medicine). Samples were collected every 621 
20 min and immediately analyzed for dopamine content by HPLC with electrochemical 622 
detection, as previously described57. When a stable baseline was obtained (three 623 
consecutive samples with a variance not exceeding 15%), THC (2.5 mg kg-1, 2 ml kg-1) 624 
was i.p. administered and sample collection continued for two hours. On completion of the 625 
testing, rats were sacrificed by Equithesin overdose, the brains were removed and 626 
sectioned by a cryostat (Leica CM3050 S) in 40 µm thick coronal slices to verify the 627 
anatomical locations of dialysis probes. 628 
Electrophysiological recordings. The preparation of VTA slices was performed as 629 
described previously67. Briefly, a block of tissue containing the midbrain was obtained from 630 
male offspring deeply anesthetized with isoflurane and sliced in the horizontal plane (300 631 
µm) with a vibratome (Leica) in ice-cold low-Ca2+ solution containing the following (in mM): 632 
126 NaCl, 1.6 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 0.625 CaCl2, 18 NaHCO3, and 11 glucose. 633 
Slices were transferred to a holding chamber with aCSF (37°C) saturated with 95% O2 and 634 
5% CO2 containing the following (in mM): 126 NaCl, 1.6 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 635 
CaCl2, 18 NaHCO3, and 11 glucose. Slices were allowed to recover for at least 1 h before 636 
being placed, as hemislices, in the recording chamber and superfused with aCSF (36-637 
37°C) saturated with 95% O2 and 5% CO2. Cells were visualized with an upright 638 
microscope with infrared illumination (Axioskop FS 2 plus; Zeiss), and whole-cell patch-639 
clamp recordings were made by using an Axopatch 200B amplifier (Molecular Devices). 640 
Recordings were carried out in the lateral portion of the VTA (supplementary Fig. 10a,b). 641 
Voltage-clamp recordings of evoked inhibitory postsynaptic currents (IPSCs) and current-642 
clamp recordings were made with electrodes filled with a solution containing (in mm): 144 643 
KCl, 10 HEPES, 3.45 BAPTA, 1 CaCl2, 2.5 Mg2ATP, and 0.25 Mg2GTP, pH 7.2–7.4, 275–644 
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285 mOsm. All GABAA IPSCs were recorded in the presence of 2-amino-5-645 
phosphonopentanoic acid (AP5; 100 µm), 6-cyano-2,3-dihydroxy-7-nitro-quinoxaline (10 646 
µm), strychnine (1 µm), and eticlopride (100 nm) to block NMDA, AMPA, glycine, and 647 
dopamine D2-mediated synaptic currents, respectively. As described previously68, this 648 
solution had no effect on the holding current of the dopamine cells. Current-clamp 649 
experiments were performed in the absence of any pharmacological blocker, i.e., in 650 
regular aCSF.  Experiments were begun only after series resistance had stabilized 651 
(typically 10–30 MΩ), which was monitored by a hyperpolarizing step of −4 mV at each 652 
sweep, every 10 s. Data were excluded when the resistance changed >20%. Voltage-653 
clamp recordings of evoked excitatory PSCs (EPSCs) were made with electrodes filled 654 
with a solution containing (in mm): 117 Cs methansulfonic acid, 20 HEPES, 0.4 EGTA, 2.8 655 
NaCl, 5 TEA-Cl, 0.1 mM spermine, 2.5 Mg2ATP, and 0.25 Mg2GTP, pH 7.2-7.4, 275-285 656 
mOsm. Picrotoxin (100 μm) was added to the aCSF to block GABAA receptor-mediated 657 
IPSCs. In addition, random experiments were performed with an internal solution added 658 
with biocytin (0.2%) to allow for subsequent immunocytochemical detection of TH37 659 
(supplementary Fig. 10e-g). Series and input resistance were monitored continuously on-660 
line with a 5 mV depolarizing step (25 ms). Data were filtered at 2 kHz, digitized at 10 kHz, 661 
and collected on-line with acquisition software (pClamp 10.2; Molecular Devices). 662 
Dopamine neurons from the lateral portion of the posterior VTA were identified according 663 
to the already published criteria69: cell morphology and anatomical location (i.e., medial to 664 
the medial terminal nucleus of the accessory optic tract; supplementary Fig. 10a,b), slow 665 
pacemaker-like firing rate (<5 Hz), long action potential duration (>2 ms; supplementary 666 
Fig.10d), and the presence of a large Ih current (>150 pA58), which was assayed 667 
immediately after break-in, using 13 incremental 10 mV hyperpolarizing steps (250 ms) 668 
from a holding potential of −70 mV (Supplementary Fig. 10c). Putative GABA neurons of 669 
the lateral VTA were identified by their morphology, the absence of Ih and a short action 670 
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potential duration (>2 ms) (Supplementary Fig. 10h,i). In addition, random experiments 671 
were performed with an internal solution added with biocytin (0.2%) to allow for 672 
subsequent immunocytochemical detection of TH37, since GABA cells are TH negative 673 
(supplementary Fig. 10j-l).  674 
Spike fidelity was measured as the reliability to elicit an action potential in response to 675 
somatically injected current (50-200 pA): the jitter, which is equal to the standard deviation 676 
of the latency to elicit the first action potential, inversely correlates with spike fidelity as the 677 
smaller the jitter the higher degree of temporal precision exhibited by the cell. A bipolar, 678 
stainless steel stimulating electrode (FHC) was placed ∼100-200 μm rostral to the 679 
recording electrode and was used to stimulate at a frequency of 0.1 Hz. Paired stimuli 680 
were given with an interstimulus interval of 50 ms, and the ratio between the second and 681 
the first PSCs (PSC2/PSC1) was calculated and averaged for a 5 min baseline59. NMDA 682 
EPSCs were evoked while holding cells at +40 mV. The AMPA EPSC was isolated after 683 
bath application of the NMDA antagonist D-AP5 (100 µM). The NMDA EPSC was obtained 684 
by digital subtraction of the AMPA EPSC from the dual (AMPA+NMDA-mediated) EPSC 685 
60. The values of the AMPA/NMDA ratio may be underestimated since the experiments 686 
were performed in the presence of spermine in the recording pipette. The spontaneous 687 
miniature EPSCs (mEPSCs) and IPSCs (mIPSCs) were collected in the presence of 688 
lidocaine (500 μM) or TTX (1 μM) and analyzed (120 sweeps for each condition, 1 689 
sec/sweep) using Mini Analysis program (Synaptosoft, Decatur, GA). To accurately 690 
determine the minis amplitude, only events that were >8 pA were accepted for analysis 691 
(rise time <1 msec, decay time <3 msec). The choice of this cutoff amplitude for 692 
acceptance of minis was made to obtain a high signal-to-noise ratio. Then, each event was 693 
also visually inspected to prevent noise disturbance of the analysis. Experiments were 694 
performed blind to the experimental group.  695 
 696 
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Immunostaining. For a detailed protocol see Barna et al. 61 Rats were transcardially 697 
perfused with 4% (m/v) PFA or immersion-fixed in 4% PFA overnight and 20, 40 or 50 μm-698 
thick sections of the midbrain were cut using a Leica VT-1000S Vibratome in phosphate 699 
buffer (PB). Immunostaining was performed in a free-floating manner. After extensive 700 
washing in PB and 0.05 M Tris-buffered saline (TBS, pH = 7.4), slices were blocked and 701 
permeabilized with 5% (v/v) Normal Donkey Serum (NDS, Sigma) and 0.3% (v/v) Triton X-702 
100 (Sigma) in TBS for 45 min, then they were incubated in primary antibodies (see Table 703 
1) in TBS while rinsed on an orbital shaker. Sections were then washed in TBS and 704 
incubated with the appropriate secondary antibodies (see Table 1) supplemented with 705 
DAPI (1:1000), if needed, then extensively washed in TBS and PB.  706 
For confocal imaging sections were mounted in VectaShield (Vector Laboratories) or 707 
Prolong Diamond (Invitrogen) Antifade Mounting Medium. Confocal imaging was 708 
performed on the samples, and tyrosine hydroxylase (TH) -positive cell density and TH-709 
immunofluorescence intensity were calculated on the images within the region of interest 710 
(ROI). vGluT1 and VIAAT inputs of the filled DAergic cells were counted in a ~1um 711 
neighborhood of the cells and input density was calculated based on the surface of the 712 
processes. Objects with a volume lower than 0.02 μm3 were considered as noise and 713 
excluded from the analysis.  714 
For STORM imaging sections were post-fixed in 4% PFA for 10 min and washed in PB. 715 
Samples were then mounted and dried on acetone-cleaned #1.5 borosilicate coverslips. 716 
 717 
Correlated confocal and STORM imaging. Samples were covered with freshly prepared 718 
STORM imaging medium as previously described62 and containing: 0.1 M 719 
mercaptoethylamine, 5% (m/v) glucose, 1 mg ml-1 glucose oxidase and catalase (2.5 720 
μl/ml of aqueous solution from Sigma, approximately 1,500 U ml-1 final concentration) in 721 
Dulbecco's PBS (Sigma). Coverslips were sealed with nail polish. Imaging started after 10 722 
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minutes and was performed for up to 3 hours. Images were acquired by a Nikon Ti-E 723 
inverted microscope equipped with a Nikon N-STORM system, CFI Apo TIRF 100× 724 
objective (1.49 NA), a Nikon C2 confocal scan head and an Andor iXon Ultra 897 EMCCD 725 
(with a cylindrical lens for astigmatic 3D-STORM imaging63). Nikon NIS-Elements AR 726 
software with N-STORM module was used to control the imaging process. A 300-mW 727 
laser (VFL-P-300-647, MPB Communications) fiber-coupled to the laser board of the 728 
microscope setup was used for STORM imaging. The field of view was selected using the 729 
live EMCCD image with a 488-nm illumination and VIAAT-positive axon terminals 730 
impinging on TH-positive cell bodies and dendrites were selected. A three-channel 731 
confocal stack (512 × 512 × 15 pixels, 78 × 78 × 150 nm resolution) was then collected 732 
using 488-nm, 561-nm, and 647-nm excitations. After brief bleaching, direct STORM 733 
imaging was performed with 10,000 cycles of 30 ms exposure, with continuous low-power 734 
activator laser (405 nm) and maximal power reporter laser (647 nm) using a STORM filter 735 
cube (Nikon) and the EMCCD camera. 736 
 737 
Correlated confocal and STORM image processing. Confocal image stacks were 738 
deconvolved with 100 iterations of the Classic Maximum Likelihood Estimation algorithm in 739 
Huygens software (SVI). STORM image processing was performed using the N-STORM 740 
module of the NIS-Elements AR. The peak detection threshold was set to 1,000 gray 741 
levels. Correlated confocal and STORM image analysis was performed using the 742 
VividSTORM software61. The data from the two imaging modalities were aligned manually 743 
based on the correlated STORM and confocal channels. One axon terminal was selected 744 
per image from the center of the field of view. The borders of the axon terminals and the 745 
outline of the active zones (for CB1 STORM and bassoon STORM, respectively) were 746 
delineated by the Morphological Active Contour Without Edges (MACWE) algorithm77 747 
using the appropriate confocal channels. STORM localization points (LPs) belonging to the 748 
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ROI were stored and counted and were normalized to the overall density of LPs per 749 
image. Size of the active zone was determined from the active contour ROIs, and the 750 
density of bassoon staining in the active zone was calculated by the division of bassoon 751 
number of LPs and the active zone size. Size of the axon terminals was also determined 752 
with the MACWE method using the VIAAT confocal channel, and the sum intensity of the 753 
VIAAT confocal staining was calculated in the ROIs to estimate transporter levels. Figures 754 
were prepared using Photoshop CS5 (Adobe Systems). All images were modified in the 755 
same way for all treatment groups during preparation of the figures to ensure equal 756 
comparison. 757 
 758 
Statistical analysis. No statistical methods were used to predetermine the number of 759 
animals and cells required. Sample sizes were estimated based on previous experience 760 
and are similar to those reported in previous publications37, 64, 65 and generally employed in 761 
the field. The animals were randomly assigned to each group at the prenatal 762 
pharmacological treatment or behavioral tests. Statistical analysis was conducted with 763 
GraphPad Prism 6 (San Diego). Statistical outliers were identified with the Grubb’s test 764 
(α=0.05) and excluded from the analysis. Data sets were tested for normality using 765 
Kolmogorov-Smirnov test and differences between animals within a treatment group using 766 
Kruskal-Wallis test to determine the appropriate statistical method. For STORM imaging 767 
mean values of each animals were used in the statistics, differences between the groups 768 
were determined using Mann-Whitney U-test. Data always met the assumptions of the 769 
applied statistical probes. Electrophysiological data were analyzed by using two-way 770 
ANOVA for repeated measures (treatment × time), or one-way ANOVA or Student's t test 771 
when appropriate, followed by Sidak’s, Dunnett's or Bonferroni's post hoc test. Behavioral 772 
parameters were analyzed by one-way or multiway ANOVAs followed by Tukey or Fisher 773 
LSD’s test for post hoc comparisons. Correlation analyses were conducted by Pearson 774 
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correlation coefficient. The significance threshold was set at 0.05. Data collection and 775 
analysis were performed blind to the conditions of the experiments. 776 
The datasets generated and analyzed during the current study are available from the 777 
corresponding author on reasonable request. 778 
 779 
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Figure Legends  858 
Figure 1. PCE elicits behavioral susceptibility to THC in male rat offspring. THC (2.5 859 
mg kg-1, s.c.) induces sensorimotor-gating deficits in male (a), but not female (b), 860 
progenies as measured by PPI index (males, PCE-VEH vs PCE-THC: *P=0.037; CTRL-861 
VEH: n= 14; PCE-VEH, PCE-THC: n= 18; CTRL-THC: n= 17; females: P=0.44 between 862 
groups; CTRL-VEH: n= 8; PCE-VEH: n= 9; CTRL-THC: n=7; PCE-THC: n= 11). (c) THC 863 
induces larger dopamine (DA) increase in PCE nucleus accumbens (NAc) shell (*P<0.05 864 
between groups; Sidak’s test). Data represent mean ± S.E.M. Inset indicates DA basal 865 
values, pg/sample (P= 0.205; two-tailed unpaired t-test; n= 7 per group). (d) PPI% values 866 
inversely correlate with NAc DA levels of THC-treated PCE offspring. Data are fit by linear 867 
regression (r2 = 0.62, P=0.01; CTRL: n= 11, PCE: n= 9). (e) DA synthesis inhibition by 868 
alpha-methyl-para-tyrosine (AMPT, 200 mg Kg-1, i.p.) prevents THC-induced PPI deficits 869 
in PCE progeny (***P=0.0008, PCE-VEH-THC vs PCE-AMPT-THC; CTRL-VEH-THC, 870 
PCE-VEH-THC: n= 10 per group, CTRL-AMPT-THC: n= 9, PCE-AMPT-THC: n= 13). (f) 871 
THC induces hyperlocomotion in PCE offspring (***P=0.0008, CTRL-VEH vs CTRL-THC: 872 
n= 8 per group, PCE-VEH: n= 11, PCE-THC: n= 10). (g) Gi activation prevents THC-873 
induced hyperlocomotion in PCE offspring (*P<0.05, PCE-VEH vs PCE-THC; **P=0.003, 874 
PCE-THC vs PCE-Gi-THC; PCE-VEH, PCE-Gi-VEH: n= 5 rats per group, PCE-THC: n= 8, 875 
PCE-Gi-THC: n= 7). Distance travelled is percentage of activity compared to reference 876 
group. (h) Crossing latency (***P=0.0006, PCE vs CTRL), and (i) number of stretched-877 
34 
 
attend postures (SAPs) (**P<0.01, CTRL-VEH vs CTRL-THC; ***P<0.001, CTRL-VEH vs 878 
PCE-VEH) are decreased in PCE offspring. THC does not modify latency to cross bridge 879 
(h) (P=0.36, THC vs VEH group), but reduces SAPs number (i) only in CTRL (P=0.02, 880 
THC vs VEH; CTRL-VEH: n= 8; CTRL-THC, PCE-THC: n= 8 per group, PCE-VEH: n= 10). 881 
Unless otherwise indicated, graphs depict box-and-whisker plots (including minima, 882 
maxima, and median values, and lower and upper quartiles) with single values. Data were 883 
analyzed with two-way ANOVA followed by Tukey’s test.  884 
 885 
Figure 2. PCE enhances pacemaker and evoked activity of VTA dopamine neurons 886 
in male rat offspring. (a) Representative traces of spontaneous activity of dopamine (DA) 887 
neurons in acute slices from CTRL and PCE offspring (n= 20 and 21 experiments from 888 
PCE and CTRL slices, respectively, were repeated independently with similar results 889 
obtained). PCE offspring (nrat= 10, nlitter= 6) show (b) higher spontaneous activity (top, 890 
**P=0.001 between groups; Welch's correction) and (c) lower resting membrane potential 891 
(bottom, *P=0.01 between groups), compared to CTRL offspring (nrat= 10, nlitter= 6); 892 
calibration bar: 100 ms, 20 mV. (d) PCE DA cells (nrat= 10, nlitter= 6) exhibit increased 893 
excitability in response to current somatically injected (***P=0.0001 between groups; two-894 
way RM-ANOVA followed by Bonferroni) when compared to CTRL cells (nrat= 10, nlitter= 895 
6). Data are represented as average values per animal ± S.E.M. Insets show 896 
representative traces of evoked action potentials (APs) in response to maximum current 897 
injected; calibration bar: 400 ms, 100 mV. (e) Quantification of the latency of first AP 898 
appearance in response to the smallest current injected (***P<0.001 between groups). 899 
Inset shows proportion of cells eliciting APs at 50 pA (CTRL in purple, PCE in blue). Top, 900 
Representative traces of evoked APs in response to the minimum current injected; 901 
calibration bar: 100 ms, 50 mV. (f) PCE DA cells exhibit a lower voltage threshold 902 
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(*P=0.015 between groups). (g) PCE does not affect after-hyperpolarization period (AHP) 903 
amplitude (P=0.47 between groups, ns) and (h) AHP duration (P=0.14 between groups, 904 
ns) of DA cells. Unless otherwise indicated, graphs show box-and-whisker plots (including 905 
minima, maxima, and median values, and lower and upper quartiles) with values averaged 906 
per animal and analyzed with two-sided unpaired t-test. 907 
Figure 3. PCE reduces synaptic inhibition onto dopamine neurons in male rat 908 
offspring. (a) Traces (left) and plots (right) of evoked EPSCs and IPSCs recorded from 909 
same DA cells (**P=0.002 between groups; two-sided unpaired t-test; nlitter= 5 per group). 910 
n= 10 experiments from PCE and CTRL slices were repeated independently, with similar 911 
results obtained. (b) Input-output relationships (***P=0.0004 between groups) in CTRL and 912 
PCE DA cells. n= 5 and 8 experiments from CTRL and PCE slices were repeated 913 
independently, with similar results obtained. Data are represented as mean ± S.E.M. Left-914 
hand panel shows IPSC traces; calibration bar: 5 ms, 100 pA. (c) PCE effect on inverse of 915 
squared coefficient of variation (1/CV2; ***P=0002 between groups) from (b). (d) Confocal 916 
image of VIAAT-containing terminals on a TH+-process. (e) Axon terminal from (d) 917 
decorated with bassoon-STORM number of localization points (NLPs) marking bouton 918 
active zone. n= 20 images per animal were acquired independently, with similar results 919 
obtained. (f) Bassoon density in VIAAT+ active zones (*P=0.030 between groups; two-920 
sided Mann-Whitney U-test; nlitter= 4 per group). (g) IPSC traces recorded before and 921 
after (grey) WIN55.212-2 (WIN; 0.1 μM); calibration bar: 5 ms, 100 pA. (h) Dose-response 922 
curves for WIN displaying a larger (*P=0.01 between groups) and faster (i) effect (P=0.02 923 
between groups) in PCE vs CTRL (nlitter= 4 per group). n= 8 and 6 experiments in PCE 924 
and CTRL were repeated independently, with similar results obtained. Average data per 925 
animal ± S.E.M. (j) CB1 NLP in VIAAT+ terminals (P=0.662 between groups; two-sided 926 
Mann-Whitney U-test; nlitter= 3 per group). n= 20 images per animal were acquired 927 
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independently, with similar results obtained. Unless otherwise indicated, graphs show box-928 
and-whisker plots (including minima, maxima, and median values, and lower and upper 929 
quartiles) with values representing mean of averaged experiments per animal analyzed 930 
with two-way RM-ANOVA followed by Bonferroni’s test.  931 
Figure 4. Synaptic properties of excitatory inputs onto dopamine neurons are 932 
affected by PCE in male rat offspring. (a) PCE effects on input-output relationships 933 
(****P<0.0001 between groups). n= 9 and 7 experiments from PCE and CTRL slices, 934 
respectively, were repeated independently with similar results obtained. AMPA EPSC 935 
traces are shown on the left. Data represent average values per animal ± S.E.M. (b) PCE 936 
effect on inverse of squared coefficient of variation (1/CV2) from (a) (P=0.2 between 937 
groups; two-sided Mann Whitney U-test). Data represent average values per animal ± 938 
S.E.M. (c) Data from (a) and Figure 3a (nlitter= 5 per group) showing that AMPA EPSC 939 
decay time kinetic (τ) do differ (***P=0.0004 between groups; two-sided unpaired t test). n= 940 
15 and 17 experiments from PCE and CTRL slices, respectively, were repeated 941 
independently, with similar results obtained. Insets show AMPA EPSC traces recorded at -942 
70 mV. (d) AMPA and NMDA EPSC traces recorded from DA neurons held at +40 mV; n= 943 
9 and 10 experiments from PCE and CTRL slices, respectively, were repeated 944 
independently, with similar results obtained. (e) PCE effect on AMPA/NMDA ratio 945 
(****P<0.0001 between groups; two-sided unpaired t-test). (f) Cumulative frequency 946 
distribution of AMPA/NMDA ratios (P=0.0002 between groups; two-sided Kolmogorov–947 
Smirnov test, D=1.0) recorded from CTRL (nrat= 6, nlitter= 4) and PCE rats (nrat= 7, 948 
nlitter= 5). Unless otherwise indicated, graphs show box-and-whisker plots (including 949 
minima, maxima, and median values, and lower and upper quartiles) with values 950 
representing experiments averaged per animal and analyzed with two-way RM ANOVA. 951 
Calibration bars: 10 ms, 50 pA. 952 
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Figure 5. PCE enhances post-synaptic responsiveness of dopamine neurons to 953 
excitatory stimuli in male rat offspring. (a) NMDAR EPSC decay time kinetic (weighted 954 
tau, τ) differs (****P<0.0001 between groups; two-sided unpaired t-test) between CTRL 955 
and PCE slices (nlitter= 6 per group). Box-and-whisker plots (including minima, maxima, 956 
and median values, and lower and upper quartiles) with circles representing average 957 
values per animal. n= 18 and 20 experiments from PCE and CTRL slices, respectively, 958 
were repeated independently, with similar results obtained. (b) Bimodal distribution of 959 
NMDAR EPSCs τ. (c) Dose-response curves for GluN2A antagonist PEAQX (*P=0.011 960 
between groups;). n= 6 experiments per group were repeated independently, with similar 961 
results obtained. (d) Current-voltage relationship (I–V) plot shows that PCE (nlitter= 4) 962 
affects linearity of I-V curves (+40mV: *P=0.02 between groups). (e) Traces of AMPA 963 
EPSCs recorded at -70 and +40 mV from DA neurons in CTRL and PCE offspring. n= 11 964 
and 6 experiments from PCE and CTRL slices, respectively, were repeated independently 965 
with similar results obtained. Calibration bar: 10 ms, 50 pA. (f) Dose-response curves for 966 
GluA2A antagonist NASPM displaying a larger effect (***P=0.0002 between groups) in 967 
PCE (nlitter= 2) offspring. n= 6 experiments per group were repeated independently, with 968 
similar results obtained. (g) AMPA EPSCs traces recorded at -70 mV before and after 969 
pairing low-frequency presynaptic stimulation (LFS; 1 Hz) with postsynaptic membrane 970 
depolarization (-40 mV). Calibration bar: 5 ms, 100 pA. (h) LFS (1 Hz at the arrow) induces 971 
long-term potentiation (LTP) (****P<0.0001 between groups) in PCE offspring (nrat= 5), 972 
whereas CTRL DA neurons (nrat= 4) exhibit long-term depression (LTD). n= 7 and 5 973 
experiments from PCE and CTRL slices, respectively, were repeated independently with 974 
similar results obtained. Unless otherwise indicated, data are represented as average of 975 
experiments per animal ± S.E.M. analyzed with two-way RM ANOVA. 976 
  977 
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Figure 6. Pregnenolone rescues synaptic plasticity, mitigates deficits in dopamine 978 
neuron activity and restores behavior in PCE male rat progeny. (a) Pregnenolone 979 
(PREG) treatment. (b) PREG effects on low-frequency presynaptic stimulation (LFS;1 Hz 980 
at the arrow) (P=0.02, PCE-VEH vs PCE-PREG). Thick lines represent effects from Figure 981 
5g. Data represent mean per animal ± S.E.M. Insets show traces (-70 mV) from before (1) 982 
and after LFS (2); calibration bar: 5 ms, 100 pA. n= 6 experiments per group were 983 
repeated independently, with similar results obtained. (c) Effects of PREG on resting 984 
membrane potential (****P=0.0006, PCE-VEH vs PCE-PREG; **P<0.01, PCE-VEH vs 985 
CTRL-VEH; nlitter= 5 per group).  (d) PREG effect on spontaneous activity (**P<0.01, 986 
PCE-VEH vs PCE-PREG; *P=0.02, PCE-VEH vs CTRL-VEH; nlitter= 5 per group). (e) 987 
Traces from PREG-treated offspring; calibration bar: 20 ms, 100 pA. n= 14 and 12 988 
experiments from PCE and CTRL slices were repeated independently, with similar results 989 
obtained. (f) Multimodal distribution from (d). (g) Traces of evoked firing in PREG-treated 990 
offspring; calibration bar: 400 ms, 100 mV. N of experiments are as in (c-h). (h) PREG 991 
restores evoked firing (****P<0.0001, PCE-VEH vs PCE-PREG; nlitter= 5 per group). Data 992 
represent values averaged per animal ± S.E.M. (i) PREG attenuates THC effects on NAc 993 
DA levels in PCE rats (P=0.30 between groups). Thick lines are from Figure 1c. Data 994 
represent mean ± S.E.M. (j) Basal DA values (pg/sample) (P=0.768 between groups; two-995 
sided unpaired t-test). (k) PREG prevents THC effects on PPI in PCE offspring (*P=0.032, 996 
PCE-THC-VEH vs PCE-THC-PREG; ***P=0.0004, CTRL-THC-VEH vs PCE-THC-VEH; 997 
Tukey’s test; CTRL-THC-VEH: n=17; CTRL-THC-PREG, PCE-THC-VEH, PCE-THC-998 
PREG: n= 16; nlitter=8 per group). Unless otherwise indicated, box-and-whisker plots 999 
(including minima, maxima, and median values, and lower and upper quartiles) with circles 1000 
depict average data per animal analyzed with two-way RM ANOVA followed by Sidak’s 1001 
test. 1002 
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